Cite
HARVARD Citation
Irizarry, M. et al. (n.d.). P4‐388: TRAILBLAZER‐ALZ (NCT03367403): A PHASE 2 DISEASE‐MODIFICATION COMBINATION THERAPY TRIAL TARGETING MULTIPLE MECHANISMS OF ACTION ALONG THE AMYLOID PATHWAY. Alzheimer's & dementia. pp. P1622-P1623. [Online].